×
Escitalopram in the Treatment of Impulsive-Compulsive Internet Usage Disorder: An Open-Label Trial Followed by a Double-Blind Discontinuation Phase PDF
$ 40.00
Escitalopram in the Treatment of Impulsive-Compulsive Internet Usage Disorder: An Open-Label Trial Followed by a Double-Blind Discontinuation Phase PDF quantity
$ 40.00
×
The ɑ1-Adrenergic Antagonist Prazosin Ameliorates Combat Trauma Nightmares in Veterans With Posttraumatic Stress Disorder: A Report of 4 Cases PDF
$ 40.00
The ɑ1-Adrenergic Antagonist Prazosin Ameliorates Combat Trauma Nightmares in Veterans With Posttraumatic Stress Disorder: A Report of 4 Cases PDF quantity
$ 40.00
×
Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study PDF
$ 40.00
Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study PDF quantity
$ 40.00
×
Association of Suicide and Antidepressant Prescription Rates in Japan, 1999-2003 PDF
$ 40.00
Association of Suicide and Antidepressant Prescription Rates in Japan, 1999-2003 PDF quantity
$ 40.00
×
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF
$ 40.00
Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity: A 16-Week Open-Label Extension Phase and Both Phases of a Randomized Controlled Trial PDF quantity
$ 40.00
×
Cholinesterase Inhibitor Discontinuation in Patients With Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Trials PDF
$ 40.00
Cholinesterase Inhibitor Discontinuation in Patients With Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Trials PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
